PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 21, Pages 11492
Publisher
MDPI AG
Online
2021-10-26
DOI
10.3390/ijms222111492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K/Akt/FoxO pathway mediates glycolytic metabolism in HepG2 cells exposed to triclosan (TCS)
- (2020) Jing An et al. ENVIRONMENT INTERNATIONAL
- Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma
- (2020) Oluwaseun Adebayo Bamodu et al. Cells
- CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway
- (2020) Yun Liu et al. Frontiers in Oncology
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer stem cells: A review from origin to therapeutic implications
- (2019) Mohammad Reza Atashzar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MiR-34a inhibits spinal cord injury and blocks spinal cord neuron apoptosis by activating phatidylinositol 3-kinase (PI3K)/AKT pathway through targeting CD47
- (2019) Liao Qi et al. CURRENT NEUROVASCULAR RESEARCH
- Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
- (2019) Subhayan Sur et al. Cell Communication and Signaling
- CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
- (2019) Shin Pai et al. Cells
- Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
- (2018) Ernestina M. De Francesco et al. BIOCHEMICAL JOURNAL
- CD47 promotes human glioblastoma invasion through activation of PI3K/Akt pathway
- (2018) Xuejian Liu et al. ONCOLOGY RESEARCH
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- PDK1: At the crossroad of cancer signaling pathways
- (2018) Paolo Armando Gagliardi et al. SEMINARS IN CANCER BIOLOGY
- Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
- (2018) Chuan Xing Wu et al. Theranostics
- Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery
- (2017) Manupol Tangthongkum et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway
- (2017) S.-L. Xie et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention
- (2017) Yogesh M. Bramhecha et al. MOLECULAR CANCER RESEARCH
- Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review
- (2017) Gaurav Shukla et al. Current Stem Cell Research & Therapy
- Targeting PDK1 for Chemosensitization of Cancer Cells
- (2017) Aikaterini Emmanouilidi et al. Cancers
- Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a Key Regulator of Cell Migration and Cancer Dissemination
- (2017) Laura Di Blasio et al. Cancers
- Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells
- (2016) Simona Daniele et al. ACS Chemical Neuroscience
- The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012
- (2016) Kevin D. Shield et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency
- (2016) Xiao Qi Wang et al. CELL DEATH AND DIFFERENTIATION
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer
- (2015) Shixian Lian et al. Oncotarget
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro
- (2014) Zhonglu Yang et al. MEDICAL ONCOLOGY
- The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
- (2014) Khalil A. Choucair et al. Translational Oncology
- Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
- (2014) M Signore et al. Cell Death & Disease
- AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases
- (2013) José M. Arencibia et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Isogenic radiation resistant cell lines: Development and validation strategies
- (2013) Niamh McDermott et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf V600E ::Pten –/– melanoma
- (2013) M Scortegagna et al. ONCOGENE
- PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
- (2013) J. Tan et al. Cancer Discovery
- Oral cancer: Current role of radiotherapy and chemotherapy
- (2013) SH. Huang et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells
- (2011) Zeshaan A. Rasheed et al. STEM CELLS
- Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway
- (2010) Emilie Sick et al. GLIA
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- 3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
- (2009) M. Maurer et al. CANCER RESEARCH
- Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
- (2009) Y H Zhao et al. ONCOGENE
- Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma
- (2008) C. Chen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE
- (2008) Sophie Pinner et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now